BACKGROUND: The clinical phenotype of DYT6 consists mainly of primary craniocervical dystonia. Recently, the THAP1 gene was identified as the cause of DYT6, where a total of 13 mutations have been identified in Amish-Mennonite and European families. METHODS: We sequenced the THAP1 gene in a series of 362 British, genetically undetermined, primary dystonia patients (78 with focal, 186 with segmental, and 98 with generalized dystonia) and in 28 dystonia-manifesting DYT1 patients and 176 normal control individuals. RESULTS: Nine coding mutations were identified in the THAP1 gene. Two were small deletions, 2 were nonsense, and 5 were missense. Eight mutations were heterozygous, and 1 was homozygous. The main clinical presentation of cases with THAP1 mutations was early-onset (<30 years) dystonia in the craniocervical region or the limbs (8 of 9 patients). There was phenotypic variability with laryngeal or oromandibular dystonia present in 3 cases. Four of 9 THAP1 cases developed generalized dystonia. CONCLUSIONS: The number of THAP1 mutations has been significantly expanded, indicating an uncommon but important cause of dystonia. Coding mutations account for 9 of 362 dystonia cases, indicating a mutation frequency of 2.5% of dystonia cases in the population that we have screened. The majority of cases reported here with THAP1 mutations had craniocervical- or limb-onset segmental dystonia, but we also identified 1 homozygous THAP1 mutation, associated initially with writer's dystonia and then developing segmental dystonia. Three of our patients had a nonsense or frameshift THAP1 mutation and the clinical features of laryngeal or oromandibular dystonia. These data suggest that early-onset dystonia that includes the involvement of the larynx or face is frequently associated with THAP1 mutations.
BACKGROUND: The clinical phenotype of DYT6 consists mainly of primary craniocervical dystonia. Recently, the THAP1 gene was identified as the cause of DYT6, where a total of 13 mutations have been identified in Amish-Mennonite and European families. METHODS: We sequenced the THAP1 gene in a series of 362 British, genetically undetermined, primary dystonia patients (78 with focal, 186 with segmental, and 98 with generalized dystonia) and in 28 dystonia-manifesting DYT1 patients and 176 normal control individuals. RESULTS: Nine coding mutations were identified in the THAP1 gene. Two were small deletions, 2 were nonsense, and 5 were missense. Eight mutations were heterozygous, and 1 was homozygous. The main clinical presentation of cases with THAP1 mutations was early-onset (<30 years) dystonia in the craniocervical region or the limbs (8 of 9 patients). There was phenotypic variability with laryngeal or oromandibular dystonia present in 3 cases. Four of 9 THAP1 cases developed generalized dystonia. CONCLUSIONS: The number of THAP1 mutations has been significantly expanded, indicating an uncommon but important cause of dystonia. Coding mutations account for 9 of 362 dystonia cases, indicating a mutation frequency of 2.5% of dystonia cases in the population that we have screened. The majority of cases reported here with THAP1 mutations had craniocervical- or limb-onset segmental dystonia, but we also identified 1 homozygous THAP1 mutation, associated initially with writer's dystonia and then developing segmental dystonia. Three of our patients had a nonsense or frameshift THAP1 mutation and the clinical features of laryngeal or oromandibular dystonia. These data suggest that early-onset dystonia that includes the involvement of the larynx or face is frequently associated with THAP1 mutations.
Authors: S B Bressman; D de Leon; D Raymond; P E Greene; M F Brin; S Fahn; L J Ozelius; X O Breakefield; P L Kramer; N J Risch Journal: Adv Neurol Date: 1998
Authors: Thomas Clouaire; Myriam Roussigne; Vincent Ecochard; Catherine Mathe; François Amalric; Jean-Philippe Girard Journal: Proc Natl Acad Sci U S A Date: 2005-04-29 Impact factor: 11.205
Authors: L Almasy; S B Bressman; D Raymond; P L Kramer; P E Greene; G A Heiman; B Ford; J Yount; D de Leon; S Chouinard; R Saunders-Pullman; M F Brin; R P Kapoor; A C Jones; H Shen; S Fahn; N J Risch; T G Nygaard Journal: Ann Neurol Date: 1997-10 Impact factor: 10.422
Authors: Ana Djarmati; Susanne A Schneider; Katja Lohmann; Susen Winkler; Heike Pawlack; Johann Hagenah; Norbert Brüggemann; Simone Zittel; Tania Fuchs; Aleksandar Raković; Alexander Schmidt; Hans-Christian Jabusch; Robert Wilcox; Vladimir S Kostić; Hartwig Siebner; Eckart Altenmüller; Alexander Münchau; Laurie J Ozelius; Christine Klein Journal: Lancet Neurol Date: 2009-04-01 Impact factor: 44.182
Authors: Günter U Höglinger; Joshua J Breunig; Candan Depboylu; Caroline Rouaux; Patrick P Michel; Daniel Alvarez-Fischer; Anne-Laurence Boutillier; James Degregori; Wolfgang H Oertel; Pasko Rakic; Etienne C Hirsch; Stéphane Hunot Journal: Proc Natl Acad Sci U S A Date: 2007-02-21 Impact factor: 11.205
Authors: Mark S LeDoux; Jianfeng Xiao; Monika Rudzińska; Robert W Bastian; Zbigniew K Wszolek; Jay A Van Gerpen; Andreas Puschmann; Dragana Momčilović; Satya R Vemula; Yu Zhao Journal: Parkinsonism Relat Disord Date: 2012-02-28 Impact factor: 4.891
Authors: Fabienne Clot; David Grabli; Pierre Burbaud; Magali Aya; Pascal Derkinderen; Luc Defebvre; Philippe Damier; Pierre Krystkowiak; Pierre Pollak; Eric Leguern; Chan San; Agnès Camuzat; Emmanuel Roze; Marie Vidailhet; Alexandra Durr; Alexis Brice Journal: Neurogenetics Date: 2010-11-26 Impact factor: 2.660
Authors: Katja Lohmann; Nils Uflacker; Alev Erogullari; Thora Lohnau; Susen Winkler; Andreas Dendorfer; Susanne A Schneider; Alma Osmanovic; Marina Svetel; Andreas Ferbert; Simone Zittel; Andrea A Kühn; Alexander Schmidt; Eckart Altenmüller; Alexander Münchau; Christoph Kamm; Matthias Wittstock; Andreas Kupsch; Elena Moro; Jens Volkmann; Vladimir Kostic; Frank J Kaiser; Christine Klein; Norbert Brüggemann Journal: Eur J Hum Genet Date: 2011-08-17 Impact factor: 4.246
Authors: Jianfeng Xiao; Yu Zhao; Robert W Bastian; Joel S Perlmutter; Brad A Racette; Samer D Tabbal; Morvarid Karimi; Randal C Paniello; Zbigniew K Wszolek; Ryan J Uitti; Jay A Van Gerpen; David K Simon; Daniel Tarsy; Peter Hedera; Daniel D Truong; Karen P Frei; Andrew Blitzer; Monika Rudzińska; Ronald F Pfeiffer; Carrie Le; Mark S LeDoux Journal: Mov Disord Date: 2011-03-02 Impact factor: 10.338
Authors: Andreas Puschmann; Jianfeng Xiao; Robert W Bastian; Jill A Searcy; Mark S LeDoux; Zbigniew K Wszolek Journal: Parkinsonism Relat Disord Date: 2011-05-20 Impact factor: 4.891